share_log

北京市金杜律师事务所关于荣昌生物制药(烟台)股份有限公司2023 年第二次临时股东大会、 2023 年第一次 A 股类别股东大会及 2023 年第一次 H 股类别股东大会法律意见书

Legal Opinions of Beijing Jindu Law Firm on the 2023 Second Extraordinary General Meeting of Shareholders of Rongchang Biopharmaceuticals (Yantai) Co., Ltd., the first Class A Shareholders\' Meeting in 2023, and the First Class H Shareholders\' Meeting in

Sensex a share ·  Dec 28, 2023 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more